Adkins S, Gan K N, Mody M, La Du B N (1993) Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes. Am J Hum Genet52: 598-608
2.
Burchfiel J L, Duffy F H, Sim V M (1976) Persistent effect of sarin and dieldrin upon the primate electroencephalogram. Toxicol Appl Pharmacol35: 365-379
3.
Davies H G, Richter R J, Keifer M, Broomfield C A, Sowalla J, Furlong C E (1996) The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin. Nature Genet14: 334-336
4.
Haley R W, Kurt T L (1997) Self-reported exposure to neurotoxic chemical combinations in the Gulf War: a cross-sectional epidemiologic study. JAMA277: 231-237
5.
Haley R W, Hom J, Roland P S, Bryan W W, Van Ness P C, Bonte F J, Devous M D Sr, Mathews D, Fleckenstein J L, Wians F H Jr, Wolfe G I, Kurt T L (1997a) Evaluation of neurologic function in Gulf War veterans: a blinded case-control study. JAMA277: 223-230
6.
Haley R W, Kurt T M, Hom J (1997b) Is there a Gulf War syndrome? Searching for syndromes by factor analysis of symptoms. JAMA277: 215-222
7.
Haley R W, Billecke S, La Du B N (1999) Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans. Toxicol Appl Pharmacol157: 227-233
8.
Humbert R, Adler D A, Disteche C M, Hassett C, Omiecinski C J, Furlong C E (1993) The molecular basis of the human serum paraoxonase activity polymorphism. Nature Genet3: 73-76
9.
La Du B N (1992) Human serum paraoxonase/arylesterase. In Kalow, W (ed.), Pharmacogenetics of drug metabolism. Pergamon Press, Inc., New York, pp. 51-91
10.
Li W F, Costa L G, Furlong C E (1993) Serum paraoxonase status: a major factor in determining resistance to organophosphates. J Toxicol Environ Health40: 337-346
11.
Mutch E, Blain P G, Williams F M (1992) Interindividual variations in enzymes controlling organophosphate toxicity in man. Hum Exp Toxicol11: 109-116
12.
Pearce P C, Crofts H S, Muggleton N G, Ridout D, Scott E A M (1999) The effects of acutely administered low dose sarin on cognitive behaviour and the electroencephalogram in the common marmoset. J Psychopharmacol13: 128-135
13.
Shih D M, Gu L, Xia Y R, Navab M, Li W F, Hama S, Castellani L W, Furlong C E, Costa L G, Fogelman A M, Lusis A J (1998) Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature394: 284-287
